28 filings
D
NLSP
NLS Pharmaceutics Ltd
3 Apr 24
$1.75 mm in equity / options / securities to be acquired, sold $1.75 mm, 2 investors
4:01pm
424B5
NLSP
NLS Pharmaceutics Ltd
22 Mar 24
Prospectus supplement for primary offering
10:24am
F-3
NLSP
NLS Pharmaceutics Ltd
13 Jan 23
Shelf registration (foreign)
4:03pm
D
NLSP
NLS Pharmaceutics Ltd
21 Dec 22
$30.00 mm in equity / options / securities to be acquired, sold $10.00 mm, 4 investors
4:01pm
F-3
NLSP
NLS Pharmaceutics Ltd
6 Dec 22
Shelf registration (foreign)
4:41pm
D
v1lg5m4
14 Oct 22
$4.00 mm in equity / options, sold $4.00 mm, 5 investors
6:07am
F-1
zhrnlivwit4
10 Jun 22
Registration statement (foreign)
4:43pm
424B5
vgd3nn6yzau1z
14 Apr 22
Prospectus supplement for primary offering
4:48pm
424B3
z34xsjtrhwcg2g
13 Apr 22
Prospectus supplement
8:17am
424B5
px2zno
4 Mar 22
Prospectus supplement for primary offering
4:01pm
F-3
5zp a21mes56y1rrsu
3 Feb 22
Shelf registration (foreign)
4:00pm
F-1
wlj4nqd2
20 Dec 21
Registration statement (foreign)
4:06pm
F-1/A
xw2a1 b4ejyj1qn
1 Nov 21
Registration statement (foreign) (amended)
8:30am
F-1
nx51zub7q5o
22 Oct 21
Registration statement (foreign)
4:02pm
POS AM
8yje ebzyt
30 Sep 21
Prospectus update (post-effective amendment)
4:00pm
POS AM
oant lyqz27v9aoo5sf
27 May 21
Prospectus update (post-effective amendment)
5:28pm
POS EX
x6xi5
2 Feb 21
Additional exhibits for listing
8:30am
424B4
zs43g0b
1 Feb 21
Prospectus supplement with pricing info
11:52am
8-A12B
x9lmumrf3olsnm2k2f
28 Jan 21
Registration of securities on exchange
8:30am
F-1/A
o18y2a
20 Jan 21
Registration statement (foreign) (amended)
12:00am